Press

Biotechnology, at the forefront of the fight against sepsis, one of the world's most serious and deadly conditions, with a 20% mortality rate

13/09/2024

Healthcare · Innovative drugs

• Sepsis is a potentially life-threatening condition that occurs when the body's immune system reacts in an extreme way to an infection, causing organ dysfunction. 
• 22% of sepsis survivors who have required intensive care suffer from post-traumatic stress disorder, and 17% of survivors experience moderate to severe cognitive impairment. 
• The use of artificial intelligence or an innovative approach focused on measuring NLRP3 inflammasome activation in monocytes ex vivo are examples of the latest advancements against sepsis.
  
   

AseBio

Biotechnology Applied to Agriculture: Key to Addressing Challenges Such as Hunger, Climate Change, and Population Growth

09/09/2024

Climate change · Agrifood · Food & feed · Agriculture

• The optimization of soil nutrient utilization, crops better adapted to climate change, or maximizing pest control through the digitalization of pesticide application are among the main areas of development.
• Genetic modification offers the opportunity to make more precise, faster, and necessary changes in the face of challenges such as climate change, population growth, and limited resources.
• On November 19, 2024, Pamplona will host the fifth edition of the Green Innovation Forum, which will explore the opportunities biotechnology offers in the transition toward a more sustainable and carbon-neutral economy.

AseBio

AseBio and the Ministry of Health analyze the challenges and opportunities of Artificial Intelligence in health data spaces

25/06/2024

Healthcare · Access to innovation

• The event "Challenges and Opportunities for Spain in the Application of AI in Health Data Spaces," organized by AseBio together with the Ministry of Health, brought together leading organizations from across the value chain to address the specificities and challenges in the use of AI in the healthcare sector.
• We are at a crucial moment for the development of health data spaces at the European, national, and regional levels; these represent an opportunity to lead the improvement of healthcare, data management, and to drive research and new biotechnological developments.
• The event shares experiences from national organizations representing the entire ecosystem, with the aim of eliminating potential knowledge barriers that hinder proper collaboration.
  
   

AseBio

Investment in R&D by biotech companies grows by 17% to 1,218 million euros

12/06/2024

Healthcare · Agrifood · Industrial biotechnology

• In 2022, the activity of biotech companies in Spain generated more than 16.6 billion euros in revenue, representing 1.5% of the national GDP.
• Private funding raised by the sector reached an all-time high, surpassing 228 million euros after a 37% increase.
• The number of biotech companies in Spain grew by 8.5% in 2022, reaching a total of 974.
• Biotech companies maintained the second position in the ranking of sectors with the highest percentage of researchers relative to total employees, with 13.77%.
  
   

AseBio

Biotechnology revolutionizes early detection of prostate cancer, the incidence of which could increase by 35% in the next few years

11/06/2024

Healthcare · Access to innovation · Digitalization

• Biotechnology is central to the diagnosis, treatment and follow-up of prostate cancer and plays a broad role across the spectrum of patient care.
• Telomere measurement technology represents a useful novelty in the diagnosis of prostate cancer, and could be useful in other types of cancer as well.
• The integration of AI in the diagnostic phases aims to optimize workflows and improve accuracy and efficiency in the early detection of this disease, increasing the chances of successful treatment.

 

AseBio

Biotechnology: key to addressing the triple environmental crisis and achieving the Sustainable Development Goals

05/06/2024

Climate change · Bioeconomy · Circular economy

• Biotechnology addresses environmental challenges through bioremediation, the production of renewable energy, sustainable agriculture, or the reduction of greenhouse gas emissions.
• Biofuels are one of the main alternatives to mitigate the impact of climate change. Bioenergy and biofuels include alternatives such as biodiesel, bioethanol, biogas, biomethane, biohydrogen or biomass.
• Biotechnological solutions in biostimulants and biofertilizers allow mitigating the effects of climate change, making better use of nutrients.

AseBio

Collaboration, efficient management of intellectual property and creation of spin-offs, vital for technology transfer and a thriving innovation ecosystem

29/05/2024

Healthcare · Access to innovation

• AseBio has organized, within the framework of the XVII Annual Conference of Biomedical Research Technology Platforms (Barcelona), the debate entitled “Collaboration and transfer: the DNA of biomedical research”.
• Collaboration between the different links in the transfer chain is crucial. It is a key element in the creation and strengthening of the business fabric and, in Spain, it is fundamental for the development of the biotechnology sector.
• Strong intellectual property protection is essential for the competitiveness of companies, and spin-offs are particularly useful for attracting investment, strengthening links between academia and industry, and boosting job creation and economic growth.
   

AseBio

From precision farming to the insect industry: how biotechnology is responding to the global challenge of hunger

28/05/2024

Climate change · Agrifood · Food & feed · Agriculture · Animal health

• Biotechnology is a cornerstone for the agri-food industry and for transforming food systems, as well as for addressing the underlying causes of food security and malnutrition.
• Thanks to precision agriculture, farmers can apply the exact amount of water, fertilizers and pesticides needed, thus reducing waste and production costs
• The insect industry will reach an estimated global production of 870,000 tons by 2030 and employ more than 30,000 people. 

AseBio

Effective and flexible regulatory policies, increased investment in R&D, and social awareness are pending tasks for Spain in the development of the bioeconomy

16/05/2024

Agrifood · Agriculture · Bioeconomy · Circular economy

• During the celebration of the AseBio Investor Day 2024, several experts analyzed the challenges and opportunities of the bioeconomy sector in Spain.
• Since 2010, as part of the Europe 2020 Strategy, the bioeconomy has been identified as a key element for sustainable growth in Europe, with leading countries such as Finland or Germany.
• At the regulatory and political level, Spain has had the Integral Bioeconomy Strategy since 2015, but it has barely evolved over time and has not achieved a significant impact.
  
   

AseBio